BioSpace News Archive

Business

Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement With Chindex Medical

“Chindex Medical organized powerful events to broaden awareness of the SRT-100 and keloid treatment in China, and we are delighted to extend our distribution and marketing agreement for the next three years,” said Joe Sardano, chief executive officer of Sensus Healthcare.

November 1, 2017

·

8 min read

Business

Viking Therapeutics to Report Financial Results for Third Quarter 2017 on November 8, 2017

Brian Lian, Ph.D., Viking’s president and CEO, and Michael Morneau, Viking’s CFO, will host a conference call to discuss financial results and general corporate updates beginning at 4:30 p.m. Eastern Time on Wednesday, November 8, 2017.

November 1, 2017

·

2 min read

Biotech Bay

Ava Clinical Trials Indicate Potential Future Use in Pregnancy Detection

Avatoday announced that results from a recent clinical study indicates that the device’s sensor technology has potential for future use in pregnancy detection.

November 1, 2017

·

2 min read

Alzheimer’s Drug Discovery Foundation’s New Report Highlights Innovation in Alzheimer’s Clinical Trials

The report, released today by the Alzheimer’s Drug Discovery Foundation, identifies the drugs for Alzheimer’s that have reached human clinical trials.

November 1, 2017

·

2 min read

Business

Natera Chosen for Longitudinal Circulating Tumor DNA Study in Breast Cancer

Natera has entered into a research collaboration with Imperial College London and the University of Leicester, U.K., to leverage the company’s Signatera personalized ctDNA technology to evaluate retrospectively the use of ctDNA to detect disease recurrence in women breast cancer patients.

November 1, 2017

·

6 min read

Deals

Ethismos Research Closes Deal to Acquire the Intellectual Property Assets of Euthymics Bioscience

This is comprised of twelve families of patents and patent applications including those underlying amitifadine, a serotonin-preferring triple reuptake inhibitor previously under phase 2 development by Euthymics.

November 1, 2017

·

4 min read

Kadmon to Present New Data From Ongoing Phase II Study of KD025 in cGVHD at ASH Annual Meeting

The data will be presented as a poster at the 59th ASH Annual Meeting in Atlanta, December 9-12, 2017.

November 1, 2017

·

5 min read

Biotech Bay

Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange, Named 2017 Scrip Award Executive of the Year Finalist

Dr. Iorns is one of six C-level executives recognized in the Executive of the Year category for private companies or those with a market capitalization of <$1 billion.

November 1, 2017

·

3 min read

Jaguar Health Subsidiary Napo Pharmaceuticals Launches New Website for Mytesi, Napo’s FDA-Approved, First-in-Class Anti-Secretory Human Prescription Drug

Jaguar Health announced today that its wholly-owned subsidiary, Napo Pharmaceuticals, Inc. (Napo), has launched a significantly enhanced version of Mytesi.com, the website for Mytesi® (crofelemer),

November 1, 2017

·

3 min read

Genetown

Magenta Therapeutics to Present Clinical Results and Preclinical Research at of ASH Annual Meeting

Magenta Therapeutics announced that the Company will present clinical data from its stem cell expansion program and insights into its preclinical research at the 59th annual meeting of the ASH.

November 1, 2017

·

3 min read